Five minutes with ... Jeanna Wacker, partner at Kirkland & Ellis

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Five minutes with ... Jeanna Wacker, partner at Kirkland & Ellis

Wacker, Jeanna_Official.jpg

Each week Managing IP speaks to a different IP lawyer about their life and career

Welcome to the second instalment of Managing IP’s new series, ‘Five minutes with’, where we learn more about IP lawyers on a personal as well as a professional level. This time we have Jeanna Wacker, partner at Kirkland & Ellis in New York.

Someone asks you at a party what you do for a living. What do you say?

I usually say I am a trial lawyer, which means I go to court, and I focus in life sciences-related patent litigation. The case example I have recently been giving is the patent litigation we are handling for Moderna relating to their Spikevax COVID vaccine, as most people are familiar with the company and product.

Talk us through a typical working day.

I have a child in elementary school so my typical work day may be a bit different than others. I generally log in early to go through late-night emails and emails from foreign clients before school dropoff. I prefer working from the office so I then spend the day at the office until I try to leave to have dinner with my family. Most evenings I end up logging back in and working until around 10pm or 11pm.

What are you working on at the moment? Does one big piece of work usually take priority or are you juggling multiple things?

Currently I am working on a number of matters for companies including Moderna, Bristol Myers Squibb, Alcon, Boehringer Ingelheim, Vertex Pharmaceuticals, and Samsung Bioepis. It ebbs and flows on cases depending on when I need to be in court or filing a particular motion. On a given day I can be working with my team on several at once.

What is the most exciting aspect of your role and what is the most stressful?

The most exciting aspect of my role is going to trial, which can also be the most stressful. I really enjoy challenging situations with multiple moving pieces and trial is my opportunity to put all those pieces together and tell our story to the judge or jury.

Tell us the key characteristics that make a successful IP lawyer.

To be a successful IP trial lawyer you have to be able to explain complex technology and concepts to a layperson which can be very challenging. For me, that can often mean understanding medical and pharma topics well enough that I can explain them easily to a judge or jury.

What is the most common misconception about IP?

The most common misconception about IP is that you have to be a nerdy scientist with a PhD to be an IP lawyer. Having a science background can help, but it is also helpful to have individuals on the trial team who are better able to view our case themes from the standpoint of the trier of fact, who generally does not have a science background.

What or who inspires you?

I have worked on a team for almost 20 years with two very successful senior female IP trial lawyers. It has been great to practise most of my career on diverse teams with people like them.

If you weren’t an IP lawyer, what would you be doing?

I would travel the world if I weren’t an IP lawyer.

Any advice you would give your younger self?

I am very happy with my career path, which wasn’t entirely planned. The advice I would give my younger self is to live in the moment more and try not to stress as much about the future.

more from across site and SHARED ros bottom lb

More from across our site

The industry’s response to AI requires an unfamiliar ingredient as firms battle to shape their futures
The firm is looking beyond replacing recently departed talent, betting instead on senior leaders to strengthen and expand its patent litigation platform
Olga Partington, director in Sterne Kessler’s biotechnology and chemical practice group, shares why a patent's vulnerability peaks when it is young, rather than when it is most valuable, under the PTAB's new framework
IP experts gathered in San Francisco last week to discuss the changing global SEP landscape and new licensing models for AI infrastructure
SKW Schwarz partner Daniel Kendziur explains how new green claims rules are changing his workload and bringing him into direct contact with marketing, PR and government affairs teams
The government is targeting earlier resolution of SEP disputes while ruling out a standalone IPEC rate determination track and restrictions on injunctions
Ana Castedo, who brings a strong focus on patent litigation, will help build the firm’s IP litigation offering in Madrid
A former scientist, inventor and now a patent practice leader, Hanane Fathi Roswall shares her views on leadership, diversity, the rise of AI and the promise of the UPC
With rumours that a third IP judge could yet join the England and Wales High Court, we run through some potential names while practitioners outline the importance of a well-stocked bench
Speaking to Managing IP at Via’s Bridge Summit in San Francisco, president Kevin Mack explains why the AI infrastructure boom is forcing a rethink of traditional SEP licensing and FRAND models
Gift this article